ADAP - Adaptimmune Therapeutics plc Stock Trading
Adaptimmune Therapeutics plc Company Name:
ADAP Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
PHILADELPHIA and OXFORDSHIRE, U.K., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for Q3 2020, before the U.S. markets open on Thursday, November 5, 2020. Fo...
-
Adaptimmune Therapeutics (NASDAQ: ADAP) , a clinical-stage cancer specialist, is having another off day today. Specifically, the biotech's shares are down by 16.8% as of 10:55 a.m. EDT Friday morning. For the week, Adaptimmune's stock is now down by over 20%. What's behind this ...
-
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader in cell therapy to treat cancer is aware of the early release of the abstract entitled “Initial safety, efficacy, and pr...
Important Investor News Alert (OTCMKTS: HIHI)
-
Holiday Island, Arkansas--(Newsfile Corp. - October 26, 2020) - Holiday Island Holdings, Inc. (OTC PINK: HIHI) - operating in the recreational and remote living real estate market - released the news today that it is planning to enter into a joint venture arrangement to acquire and operate an ...